NRC Health Director John N. Nunnelly Receives Restricted Stock Units Award

This SEC Form 4 filing reports that John N. Nunnelly, a director of NRC Health, received an annual equity compensation award of 7,697 restricted stock units on June 23, 2026. The award represents $150,000 worth of common stock, calculated based on the closing price preceding the company's 2026 annual meeting. The restricted stock units were granted under NRC Health's 2025 Omnibus Incentive Plan and will vest on the date of the company's 2027 annual stockholder meeting, subject to standard vesting, forfeiture, and termination provisions. Following this transaction, Nunnelly's total holdings in NRC Health common stock increased to 40,363 shares. The filing was signed by Christopher Kortum as attorney-in-fact for Nunnelly on June 25, 2026.